The quarter ended March 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 543.48 millions.Net Profit for the quarter ended March 2026 zoomed to 282.29% from Rs. 13.95 millions to Rs. 53.33 millions.Operating Profit saw a handsome growth to 126.73 millions from 91.77 millions in the quarter ended March 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	543.48	537.36	1.14	2254.30	2202.00	2.38	2254.30	2202.00	2.38
Other Income	29.18	39.27	-25.69	111.43	61.92	79.96	111.43	61.92	79.96
PBIDT	126.73	91.77	38.10	396.87	376.08	5.53	396.87	376.08	5.53
Interest	28.74	28.06	2.42	118.07	47.56	148.25	118.07	47.56	148.25
PBDT	97.99	41.49	136.18	278.80	282.82	-1.42	278.80	282.82	-1.42
Depreciation	27.40	21.38	28.16	96.69	74.42	29.92	96.69	74.42	29.92
PBT	70.59	20.11	251.02	182.11	208.40	-12.62	182.11	208.40	-12.62
TAX	17.26	6.16	180.19	38.77	54.08	-28.31	38.77	54.08	-28.31
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	53.33	13.95	282.29	143.34	154.32	-7.12	143.34	154.32	-7.12
Equity	101.37	100.95	0.42	101.37	100.95	0.42	101.37	100.95	0.42
PBIDTM(%)	23.32	17.08	36.54	17.61	17.08	3.08	17.61	17.08	3.08

Beta Drugs Ltd.